Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Outstanding
Ratios

Spero Therapeutics (SPRO) Receivables Refunds (2016 - 2022)

Historic Receivables Refunds for Spero Therapeutics (SPRO) over the last 7 years, with Q3 2022 value amounting to $39000.0.

  • Spero Therapeutics' Receivables Refunds fell 8859.65% to $39000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $39000.0, marking a year-over-year decrease of 8859.65%. This contributed to the annual value of $361000.0 for FY2021, which is 5732.86% down from last year.
  • As of Q3 2022, Spero Therapeutics' Receivables Refunds stood at $39000.0, which was down 8859.65% from $19000.0 recorded in Q2 2022.
  • In the past 5 years, Spero Therapeutics' Receivables Refunds ranged from a high of $1.9 million in Q1 2018 and a low of $19000.0 during Q2 2022
  • Its 5-year average for Receivables Refunds is $766105.3, with a median of $786000.0 in 2019.
  • Data for Spero Therapeutics' Receivables Refunds shows a peak YoY increase of 40135.14% (in 2022) and a maximum YoY decrease of 9450.87% (in 2022) over the last 5 years.
  • Spero Therapeutics' Receivables Refunds (Quarter) stood at $922000.0 in 2018, then dropped by 14.75% to $786000.0 in 2019, then rose by 7.63% to $846000.0 in 2020, then plummeted by 57.33% to $361000.0 in 2021, then crashed by 89.2% to $39000.0 in 2022.
  • Its Receivables Refunds stands at $39000.0 for Q3 2022, versus $19000.0 for Q2 2022 and $371000.0 for Q1 2022.